Fig. 3

CBX affects AML cell cycle and induces apoptosis. a CBX (150 µM, 48 h) reduces AML cell proliferation by reducing the number of leukemic cells in S/G2/M phases (n = 3). b, c Treatment with CBX induced AML cells apoptosis but did not affect ROS levels in AML cells neither induced DNA damage (n = 3). Results are expressed as mean ± SEM. *P < 0.05; ns nonsignificant